Position in ACAD
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$9,035,155
-$3,081,648 QoQ
Shares Held
405,892
-10.5% QoQ
Ownership
0.237%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 94.69783312144719.ToString("F0")%
Shared 0.ToString("F0")%
None 5.302166878552813.ToString("F0")%
Common Shares in ACAD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $121,614,834 across 47 Biotechnology names. ACAD ranks #5 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
523,291 | $49,252,148 | |
| 2 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
565,424 | $13,999,896 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
18,059 | $13,953,104 | |
| 4 | HALO |
Halozyme Therapeutics, Inc.
|
146,717 | $9,482,319 | |
| 5 | ACAD |
Acadia Pharmaceuticals Inc
This page
|
405,892 | $9,035,155 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,608 | $2,504,195 | |
| 7 | JAZZ |
Jazz Pharmaceuticals plc
|
7,819 | $1,478,181 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
6,716 | $1,135,138 |
All Filings in ACAD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,035,155 | 405,892 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $12,116,803 | 453,643 | Shares | Sole | 2026-02-17 | |
| 2020-12-31 | $212,877 | 3,982 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $164,505 | 3,988 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $195,237 | 4,028 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $413,247 | 9,781 | Shares | Sole | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||